|
1.
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
El-Serag HB, Marrero JA, Rudolph L and
Reddy KR: Diagnosis and treatment of hepatocellular carcinoma.
Gastroenterology. 134:1752–1763. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Visvader JE: Cells of origin in cancer.
Nature. 469:314–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
5.
|
Bomken S, Fiser K, Heidenreich O and
Vormoor J: Understanding the cancer stem cell. Br J Cancer.
103:439–445. 2010. View Article : Google Scholar
|
|
6.
|
Bjerkvig R, Tysnes BB, Aboody KS, Najbauer
J and Terzis AJ: Opinion: the origin of the cancer stem cell:
current controversies and new insights. Nat Rev Cancer. 5:899–904.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Marquardt JU, Factor VM and Thorgeirsson
SS: Epigenetic regulation of cancer stem cells in liver cancer:
current concepts and clinical implications. J Hepatol. 53:568–577.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Park YN: Update on precursor and early
lesions of hepatocellular carcinomas. Arch Pathol Lab Med.
135:704–715. 2011.PubMed/NCBI
|
|
9.
|
Litvinov SV, Balzar M, Winter MJ, et al:
Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell
interactions mediated by classic cadherins. J Cell Biol.
139:1337–1348. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Winter MJ, Nagtegaal ID, van Krieken JH
and Litvinov SV: The epithelial cell adhesion molecule (Ep-CAM) as
a morpho-regulatory molecule is a tool in surgical pathology. Am J
Pathol. 163:2139–2148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Breuhahn K, Baeuerle PA, Peters M, et al:
Expression of epithelial cellular adhesion molecule (Ep-CAM) in
chronic (necro-) inflammatory liver diseases and hepatocellular
carcinoma. Hepatol Res. 34:50–56. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Yamashita T, Ji J, Budhu A, et al:
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating
cells with stem/progenitor cell features. Gastroenterology.
136:1012–1024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Yamashita T, Forgues M, Wang W, et al:
EpCAM and alpha-fetoprotein expression defines novel prognostic
subtypes of hepatocellular carcinoma. Cancer Res. 68:1451–1461.
2008. View Article : Google Scholar
|
|
14.
|
Patriarca C, Macchi RM, Marschner AK and
Mellstedt H: Epithelial cell adhesion molecule expression (CD326)
in cancer: a short review. Cancer Treat Rev. 38:68–75. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Schmidt M, Scheulen ME, Dittrich C, et al:
An open-label, randomized phase II study of adecatumumab, a fully
human anti-EpCAM antibody, as monotherapy in patients with
meta-static breast cancer. Ann Oncol. 21:275–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Maetzel D, Denzel S, Mack B, et al:
Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell
Biol. 11:162–171. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Osta WA, Chen Y, Mikhitarian K, et al:
EpCAM is over-expressed in breast cancer and is a potential target
for breast cancer gene therapy. Cancer Res. 64:5818–5824. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Yang XR, Xu Y, Yu B, et al: High
expression levels of putative hepatic stem/progenitor cell
biomarkers related to tumour angiogenesis and poor prognosis of
hepatocellular carcinoma. Gut. 59:953–962. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Shan YF, Huang YL, Xie YK, et al:
Angiogenesis and clinicopathologic characteristics in different
hepatocellular carcinoma subtypes defined by EpCAM and
α-fetoprotein expression status. Med Oncol. 28:1012–1016.
2011.PubMed/NCBI
|
|
20.
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th ed.
Springer; New York, NY: 2010
|
|
21.
|
Bae JS, Choi HN, Noh SJ, et al: Expression
of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.
Oncol Lett. 4:213–220. 2012.PubMed/NCBI
|
|
22.
|
Kim DG, Park SY, Kim H, Chun YH, Moon WS
and Park SH: A comprehensive karyotypic analysis on a newly
established sarcomatoid hepatocellular carcinoma cell line SH-J1 by
comparative genomic hybridization and chromosome painting. Cancer
Genet Cytogenet. 132:120–124. 2002. View Article : Google Scholar
|
|
23.
|
Park YN, Kim YB, Yang KM and Park C:
Increased expression of vascular endothelial growth factor and
angiogenesis in the early stage of multistep hepatocarcinogenesis.
Arch Pathol Lab Med. 124:1061–1065. 2000.PubMed/NCBI
|
|
24.
|
Kwon CY, Kim KR, Choi HN, et al: The role
of serum response factor in hepatocellular carcinoma: implications
for disease progression. Int J Oncol. 37:837–844. 2010.PubMed/NCBI
|
|
25.
|
Shackleton M, Quintana E, Fearon ER and
Morrison SJ: Heterogeneity in cancer: cancer stem cells versus
clonal evolution. Cell. 138:822–829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Litvinov SV, van Driel W, van Rhijn CM, et
al: Expression of Ep-CAM in cervical squamous epithelia correlates
with an increased proliferation and the disappearance of markers
for terminal differentiation. Am J Pathol. 148:865–875. 1996.
|
|
27.
|
Münz M, Kieu C, Mack B, Schmitt B, Zeidler
R and Gires O: The carcinoma-associated antigen EpCAM upregulates
c-myc and induces cell proliferation. Oncogene. 23:5748–5758.
2004.PubMed/NCBI
|
|
28.
|
Yamashita T, Budhu A, Forgues M and Wang
XW: Activation of hepatic stem cell marker EpCAM by
Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res.
67:10831–10839. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Cimino A, Halushka M, Illei P, Wu X,
Sukumar S and Argani P: Epithelial cell adhesion molecule (EpCAM)
is overexpressed in breast cancer metastases. Breast Cancer Res
Treat. 123:701–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Piyathilake CJ, Frost AR, Weiss H, Manne
U, Heimburger DC and Grizzle WE: The expression of Ep-CAM (17-1A)
in squamous cell cancers of the lung. Hum Pathol. 31:482–487. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Scheunemann P, Stoecklein NH, Rehders A,
et al: Occult tumor cells in lymph nodes as a predictor for tumor
relapse in pancreatic adenocarcinoma. Langenbecks Arch Surg.
393:359–365. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
van der Gun BT, Melchers LJ, Ruiters MH,
de Leij LF, McLaughlin PM and Rots MG: EpCAM in carcinogenesis: the
good, the bad or the ugly. Carcinogenesis. 31:1913–1921.
2010.PubMed/NCBI
|
|
33.
|
Went P, Dirnhofer S, Salvisberg T, et al:
Expression of epithelial cell adhesion molecule (EpCam) in renal
epithelial tumors. Am J Surg Pathol. 29:83–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ensinger C, Kremser R, Prommegger R,
Spizzo G and Schmid KW: EpCAM overexpression in thyroid carcinomas:
a histopathological study of 121 cases. J Immunother. 29:569–573.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Winter MJ, Nagelkerken B, Mertens AE,
Rees-Bakker HA, Briaire-de Bruijn IH and Litvinov SV: Expression of
Ep-CAM shifts the state of cadherin-mediated adhesions from strong
to weak. Exp Cell Res. 285:50–58. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Schmidt DS, Klingbeil P, Schnölzer M and
Zöller M: CD44 variant isoforms associate with tetraspanins and
EpCAM. Exp Cell Res. 297:329–347. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Ladwein M, Pape UF, Schmidt DS, et al: The
cell-cell adhesion molecule EpCAM interacts directly with the tight
junction protein claudin-7. Exp Cell Res. 309:345–357. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Chaudry MA, Sales K, Ruf P, Lindhofer H
and Winslet MC: EpCAM an immunotherapeutic target for
gastrointestinal malignancy: current experience and future
challenges. Br J Cancer. 96:1013–1019. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
McCaffrey AP, Meuse L, Pham TT, Conklin
DS, Hannon GJ and Kay MA: RNA interference in adult mice. Nature.
418:38–39. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Lewis DL, Hagstrom JE, Loomis AG, Wolff JA
and Herweijer H: Efficient delivery of siRNA for inhibition of gene
expression in postnatal mice. Nat Genet. 32:107–108. 2002.
View Article : Google Scholar : PubMed/NCBI
|
